These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 28745315)
1. miR-302/367/LATS2/YAP pathway is essential for prostate tumor-propagating cells and promotes the development of castration resistance. Guo Y; Cui J; Ji Z; Cheng C; Zhang K; Zhang C; Chu M; Zhao Q; Yu Z; Zhang Y; Fang YX; Gao WQ; Zhu HH Oncogene; 2017 Nov; 36(45):6336-6347. PubMed ID: 28745315 [TBL] [Abstract][Full Text] [Related]
2. MYBL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer. Li Q; Wang M; Hu Y; Zhao E; Li J; Ren L; Wang M; Xu Y; Liang Q; Zhang D; Lai Y; Liu S; Peng X; Zhu C; Ye L Theranostics; 2021; 11(12):5794-5812. PubMed ID: 33897882 [No Abstract] [Full Text] [Related]
3. Downregulation of microRNA-224-3p Hampers Retinoblastoma Progression via Activation of the Hippo-YAP Signaling Pathway by Increasing LATS2. Song L; Huang Y; Zhang X; Han S; Hou M; Li H Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):32. PubMed ID: 32186675 [TBL] [Abstract][Full Text] [Related]
4. The hippo pathway effector YAP regulates motility, invasion, and castration-resistant growth of prostate cancer cells. Zhang L; Yang S; Chen X; Stauffer S; Yu F; Lele SM; Fu K; Datta K; Palermo N; Chen Y; Dong J Mol Cell Biol; 2015 Apr; 35(8):1350-62. PubMed ID: 25645929 [TBL] [Abstract][Full Text] [Related]
5. miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway. Wu T; Hu H; Zhang T; Jiang L; Li X; Liu S; Zheng C; Yan G; Chen W; Ning Y; Li Y; Lu Z Oxid Med Cell Longev; 2019; 2019():9719723. PubMed ID: 31316723 [TBL] [Abstract][Full Text] [Related]
6. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway. Chen M; Wang M; Xu S; Guo X; Jiang J Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204 [TBL] [Abstract][Full Text] [Related]
7. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma. Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896 [TBL] [Abstract][Full Text] [Related]
8. Identification of a tumor suppressor relay between the FOXP3 and the Hippo pathways in breast and prostate cancers. Li W; Wang L; Katoh H; Liu R; Zheng P; Liu Y Cancer Res; 2011 Mar; 71(6):2162-71. PubMed ID: 21278236 [TBL] [Abstract][Full Text] [Related]
9. YAP is closely correlated with castration-resistant prostate cancer, and downregulation of YAP reduces proliferation and induces apoptosis of PC-3 cells. Sheng X; Li WB; Wang DL; Chen KH; Cao JJ; Luo Z; He J; Li MC; Liu WJ; Yu C Mol Med Rep; 2015 Oct; 12(4):4867-76. PubMed ID: 26126522 [TBL] [Abstract][Full Text] [Related]
10. MiR-429 Involves in the Pathogenesis of Colorectal Cancer via Directly Targeting LATS2. Chen X; Wang AL; Liu YY; Zhao CX; Zhou X; Liu HL; Lin MB Oxid Med Cell Longev; 2020; 2020():5316276. PubMed ID: 33414893 [TBL] [Abstract][Full Text] [Related]
11. Transcriptional analysis of pluripotency reveals the Hippo pathway as a barrier to reprogramming. Qin H; Blaschke K; Wei G; Ohi Y; Blouin L; Qi Z; Yu J; Yeh RF; Hebrok M; Ramalho-Santos M Hum Mol Genet; 2012 May; 21(9):2054-67. PubMed ID: 22286172 [TBL] [Abstract][Full Text] [Related]
12. miR-30a inhibits androgen-independent growth of prostate cancer via targeting MYBL2, FOXD1, and SOX4. Li X; Jiao M; Hu J; Qi M; Zhang J; Zhao M; Liu H; Xiong X; Dong X; Han B Prostate; 2020 Jun; 80(9):674-686. PubMed ID: 32294305 [TBL] [Abstract][Full Text] [Related]
13. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2. Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863 [TBL] [Abstract][Full Text] [Related]
14. m Jin D; Guo J; Wu Y; Yang L; Wang X; Du J; Dai J; Chen W; Gong K; Miao S; Li X; Sun H Mol Cancer; 2020 Feb; 19(1):40. PubMed ID: 32106857 [TBL] [Abstract][Full Text] [Related]
15. Elevated expression of Par3 promotes prostate cancer metastasis by forming a Par3/aPKC/KIBRA complex and inactivating the hippo pathway. Zhou PJ; Xue W; Peng J; Wang Y; Wei L; Yang Z; Zhu HH; Fang YX; Gao WQ J Exp Clin Cancer Res; 2017 Oct; 36(1):139. PubMed ID: 29017577 [TBL] [Abstract][Full Text] [Related]
16. Muscarinic receptors promote castration-resistant growth of prostate cancer through a FAK-YAP signaling axis. Goto Y; Ando T; Izumi H; Feng X; Arang N; Gilardi M; Wang Z; Ando K; Gutkind JS Oncogene; 2020 May; 39(20):4014-4027. PubMed ID: 32205868 [TBL] [Abstract][Full Text] [Related]
17. Zyxin-Siah2-Lats2 axis mediates cooperation between Hippo and TGF-β signalling pathways. Ma B; Cheng H; Gao R; Mu C; Chen L; Wu S; Chen Q; Zhu Y Nat Commun; 2016 Mar; 7():11123. PubMed ID: 27030211 [TBL] [Abstract][Full Text] [Related]
18. LATS2 Inhibits Malignant Behaviors of Glioma Cells via Inactivating YAP. Shi Y; Geng D; Zhang Y; Zhao M; Wang Y; Jiang Y; Yu R; Zhou X J Mol Neurosci; 2019 May; 68(1):38-48. PubMed ID: 30771084 [TBL] [Abstract][Full Text] [Related]
19. Blockade of a novel MAP4K4-LATS2-SASH1-YAP1 cascade inhibits tumorigenesis and metastasis in luminal breast cancer. Yang P; Li Y; Hou J; Wu D; Zeng X; Zeng Z; Zhang J; Xiong Y; Chen L; Yang D; Wan X; Wu Z; Jia L; Liu Q; Lu Q; Zou X; Fang W; Zeng X; Zhou D J Biol Chem; 2024 Jun; 300(6):107309. PubMed ID: 38657867 [TBL] [Abstract][Full Text] [Related]
20. Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway. Zhu C; Ji X; Zhang H; Zhou Q; Cao X; Tang M; Si Y; Yan H; Li L; Liang T; Feng XH; Zhao B J Biol Chem; 2018 Jan; 293(4):1178-1191. PubMed ID: 29183995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]